Baxter Announces Third-Quarter 2024 Financial Results
Baxter International Inc. (NYSE: BAX), a global leader in medical technology, today announced its financial results for the third quarter of 2024. “Baxter achieved strong performance in Q3 2024 as…
Free Heart and Kidney Health Screenings Offered in Houston from Nov. 11-14
Care Access, a global clinical research company focused on advancing medicine, is hosting a Heart & Kidney Health Screening event in Houston, Texas. The initiative is designed to raise awareness…
Tempus to Present Nine Abstracts at the 2024 Society for Immunotherapy of Cancer Annual Meeting
Tempus AI, Inc. (NASDAQ: TEM), a leader in utilizing AI to advance precision medicine and patient care, announced today that nine abstracts have been accepted for presentation at the Society…
BeiGene Showcases Innovative Hematology Portfolio for B-cell Malignancies at ASH 2024
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced that it will present new data on a range of B-cell malignancies and treatments at the…
Tezspire Achieves Both Primary Goals in Phase III WAYPOINT Trial for Chronic Rhinosinusitis with Nasal Polyps
AstraZeneca and Amgen announced promising top-line results from the Phase III WAYPOINT trial, showing that Tezspire (tezepelumab) significantly reduced nasal polyp size and congestion in patients with chronic rhinosinusitis with…
Health Canada Approves Moderna’s RSV Vaccine for Adults 60 and Older
Moderna announced that Health Canada has approved mRESVIA™ (Respiratory Syncytial Virus mRNA vaccine) for the prevention of lower respiratory tract disease caused by RSV in adults aged 60 and older.…
Essential Facts About OTC Phenylephrine for Cold and Flu Season
Last fall, the Food and Drug Administration (FDA) recommended discontinuing the use of oral phenylephrine in over-the-counter (OTC) cold and cough products due to concerns over its effectiveness. This decision…
Royalty Pharma Acquires $125 Million Royalty Stake in Geron’s Rytelo
Royalty Pharma plc (Nasdaq: RPRX) announced an agreement to acquire a synthetic royalty on U.S. sales of Geron Corporation’s (Nasdaq: GERN) RYTELO, with a $125 million upfront cash payment. Approved…
AskBio’s AB-1003 Granted FDA Rare Pediatric Disease and Orphan Drug Designations
Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company fully owned and operated as a subsidiary of Bayer AG, announced that its investigational gene therapy, AB-1003 (also known as LION-101), has…
Gilead Presents Late-Breaking Data at HIV Glasgow, Advancing Efforts to End the Epidemic
Gilead Sciences, Inc. (Nasdaq: GILD) has announced the upcoming presentation of over 40 HIV research studies at the International Congress on Drug Therapy in HIV Infection (HIV Glasgow 2024), taking…
Allergan Aesthetics Marks Annual BOTOX® Cosmetic (onabotulinumtoxinA) Day Celebration
Allergan Aesthetics, an AbbVie company (NYSE: ABBV), is gearing up for the sixth annual BOTOX® Cosmetic Day, set for Wednesday, November 20, 2024. This special day celebrates the healthcare providers…
AstraZeneca Highlights Strength of Hematology Portfolio and Pipeline at ASH 2024
AstraZeneca will present new data from its cutting-edge hematology portfolio and pipeline at the 66th American Society of Hematology (ASH) Annual Meeting, taking place from December 7 to 10, 2024.…